Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.
- DOI
- 10.1038/s41419-023-06405-8
- Published
- 2024 Jan 11
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-023-06405-8,
title = {Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.},
author = {Rodriguez-Berriguete G and Puliyadi R and Machado N and Barberis A and Prevo R and McLaughlin M and Buffa FM and Harrington KJ and Higgins GS},
year = {2024},
journal = {Cell death \& disease},
doi = {10.1038/s41419-023-06405-8},
url = {https://doi.org/10.1038/s41419-023-06405-8}
}RIS
TY - JOUR TI - Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. AU - Rodriguez-Berriguete G AU - Puliyadi R AU - Machado N AU - Barberis A AU - Prevo R AU - McLaughlin M AU - Buffa FM AU - Harrington KJ AU - Higgins GS PY - 2024 JO - Cell death & disease DO - 10.1038/s41419-023-06405-8 UR - https://doi.org/10.1038/s41419-023-06405-8 ER -
APA
G, R., R, P., N, M., A, B., R, P., M, M., FM, B., KJ, H., & GS, H. (2024). Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.. Cell death & disease. https://doi.org/10.1038/s41419-023-06405-8
Source records
- pubmed · retrieved 2026-09-26T12:34:16.232Z